Canopy Growth Corporation (CGC)
NasdaqGS · USD · Healthcare · Drug Manufacturers - Specialty & Generic
$0.6681 (-1.14%) as of
Key statistics
- Market cap
- 300.18M
- Forward P/E
- -5.52
- EPS (TTM)
- -0.4400
- Dividend yield
- 0.00%
- 52-week range
- 0.6500 – 2.3800
- Beta
- 2.37
- Revenue (TTM)
- 293.63M
- Profit margin
- -79.22%
- Analyst target
- $0.923046
- Volume
- 1.20M
About Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Smiths Falls, ON, Canada
- Employees
- 1,128
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.